Intervention Protocol

You have free access to this content

Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradication

  1. Sheikh Uzair1,*,
  2. Paul A Sutton1,
  3. Annie Herbert2,
  4. Khawar Hashmi3,
  5. Xavier Calvet4

Editorial Group: Cochrane Upper Gastrointestinal and Pancreatic Diseases Group

Published Online: 29 NOV 2013

DOI: 10.1002/14651858.CD010819


How to Cite

Uzair S, Sutton PA, Herbert A, Hashmi K, Calvet X. Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradication (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010819. DOI: 10.1002/14651858.CD010819.

Author Information

  1. 1

    Royal Bolton Hospital, Department of Surgery, Bolton, Lancashire, UK

  2. 2

    Pennine Acute Hospitals NHS Foundation Trust, Research and Development, Manchester, UK

  3. 3

    Royal Bolton Hospital, Bolton, UK

  4. 4

    Hospital de Sabadell & Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Servei de Malalties Digestives, Sabadell, Spain

*Sheikh Uzair, Department of Surgery, Royal Bolton Hospital, Minerva Road, Bolton, Lancashire, BL4 0JR, UK. sheikh.uzair@boltonft.nhs.uk. sheikh.uzair@rbh.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 29 NOV 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

Primary objective

To assess the effectiveness of dual therapy regimens compared with standard triple therapy regimens for eradication of H pylori in people of all ages.

Secondary objectives

To compare the incidence of adverse effects and cost effectiveness of different regimens for eradication of H pylori.